William Benton Jones, See Remarks at Corvus Pharmaceuticals, Inc. (CRVS), bought 20,000 shares at $0.79 ($16K) on 2022-12-20, disclosed to the SEC on 2022-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.